Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.
They’re planning to drop the healing time by amplifying what the body already does naturally: build layers of new tissue pumped up by nitric oxide. In patients with diabetes, impaired nitric oxide production lessens the healing power of skin cells, and the Centers for Disease Control reports that 15 percent of Americans living with Type 2 diabetes struggle with hard-to-heal foot ulcers. However, simply pumping up nitric oxide is not necessarily better. The long-term plan of Michigan Technological University researchers is to create nitric oxide-infused bandages that adjust the chemical release depending on the cell conditions.
To do that, the researchers first have to figure what’s going on with nitric oxide in skin cells. Assessing nitric oxide under diabetic and normal conditions in human dermal fibroblast cells is the focus of the team’s latest paper, published this week in Medical Sciences (DOI: 10.3390/medsci6040099).
Cell-mediated Symphony of Complexity
Megan Frost is the interim chair of the Department of Kinesiology and Integrative Physiology as well as an associate professor of biomedical engineering and an affiliated associate professor of materials science and engineering. She runs a polymeric biomaterials lab at Michigan Tech where she works on nitric oxide-releasing technology.
“Nitric oxide is a powerful healing chemical, but it’s not meant to be heavy-handed,” Frost says. “We’re looking at the profiles of healthy and diabetic cells to find a more nuanced way to recover wound function.”
As a wound heals, three types of skin cells step in. Macrophages are the first responders—and the most widely studied cells—that arrive within 24 hours of damage. Next, fibroblasts arrive, which are like the body’s engineers. They help lay down the extracellular matrix that makes it possible for the next cells, keratinocytes, to do the heavy-lifting and rebuilding.
“Wound healing is a complex, cell-mediated symphony of events, progressing through a series of predictable and overlapping stages,” Frost and her team write in their Medical Sciences paper. When any part of that orchestra is out of tune, the whole process falls flat. Fibroblasts, which are not as well studied as macrophages in the healing process, are a key instrument, and past studies have shown their delayed response in patients with diabetes may be a major factor in slow healing time.
Nitric Oxide vs. Nitrite
That’s where nitric oxide steps in, a kind of chemical metronome to get the process back into the right rhythm. But the body’s dermal orchestra is not so simple—just as playing a metronome louder and louder isn’t necessarily going to make a musician’s timing improve, flooding a wound with nitric oxide isn’t a cure-all.
“The old approach is to add nitric oxide and sit back to see if it works,” Frost says. “What we’re finding is that it’s not enough to apply and leave; we have to keep tabs on how much nitric oxide is actually needed.”
A big problem that Frost and her team address is how nitric oxide is measured in the first place. Current practice substitutes measuring nitrite for nitric oxide—a misleading switch, Frost says, because nitrite is a byproduct with no time signature. While stable nitrite is easier to measure, by itself it cannot relay the real-time healing status like nitric oxide levels can.
So, Frost’s lab built a nitric oxide-measuring device for their study by hand. That creates a challenge since it means taking measurements is much harder, which limits the dataset size, but Frost has an agreement with Zysense LLC to streamline the building process and produce commercial nitric oxide measurement devices that would improve cell chemistry research.
Collaboration is a key part of the engineering design process. To build a nitric oxide bandage with personalized healing power, the team plans to work next with the UP Portage Health System to gather cell samples from local patients. By expanding their cell samples—and applying the tech to real-world patients—the team will continue to broaden their database while deepening their knowledge of nitric oxide mechanisms.
In a few years, they plan to have a working bandage prototype, one that leaves off the clunky nitrite proxies and nitric oxide dumps. Instead, patients dealing with diabetic foot ulcers will see a light at the end of the tunnel much sooner than half a year or more—the nitric oxide-releasing bandage could help heal one of health care’s toughest diseases in less than a month.
The Latest on: Diabetic ulcers
via Google News
The Latest on: Diabetic ulcers
- Century-old drug repurposed to fight ulcers in cancer, diabetic patientson May 11, 2020 at 9:01 am
Suramin, a 100-year old drug used to treat sleeping sickness, has been repurposed to fight oral mucositis and diabetic foot ulcers.
- Diabetic Foot Ulcer (DFU) Market & Drug Pipeline Analysis Market 2020 by Price, Sales, Revenue, Global Market Share and Forecast to 2026on May 11, 2020 at 3:38 am
Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Diabetic Foot Ulcer (DFU) ...
- Diabetic Foot Triage System Guides Podiatrists During COVID-19on May 10, 2020 at 11:52 pm
A recent in-press special communication in the Journal of The American Podiatric Medical Association calls physicians to action worldwide in order to reduce health-care burden and facilitate the best ...
- Can Remote Ischemic Conditioning Promote Healing In Diabetic Foot Ulcers?on May 9, 2020 at 2:46 pm
The prevalence of diabetes is on the rise worldwide. As podiatrists and diabetic foot experts, we know the deleterious effects of diabetes on the tissues of the lower extremity. Among diabetes-related ...
- How nanosensors help with diabetes treatmenton May 8, 2020 at 1:13 am
Dr. Olfa Kanoun) at Chemnitz University of Technology, was to develop sensor mats to support the treatment of pressure ulcers in patients with diabetes mellitus. A special novelty of this project is ...
- What are proton pump inhibitors, and how can they help?on May 4, 2020 at 8:15 am
Proton pump inhibitors (PPIs) can reduce heartburn, acid reflux, and stomach ulcers. However, long-term use may have serious risks. Learn more about PPIs here.
- Wound Debridement Market Worth $1,162 Million by 2025 - Exclusive Report by MarketsandMarkets™on May 4, 2020 at 4:40 am
According to the new market research report "Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot ...
- Microbial predictors of healing and short-term effect of debridement on the microbiome of chronic woundson May 1, 2020 at 2:16 am
Chronic wounds represent a large and growing disease burden. Infection and biofilm formation are two of the leading impediments of wound healing, suggesting an important role for the microbiome of ...
- Outlook on the Worldwide Wound Care Biologics Industry to 2025 - Extensive Profiles and Recent Developments of Market Playerson April 30, 2020 at 2:48 am
The report is intended for wound care biologics manufacturers, third-party suppliers and distributors, burn centers, market research firms, and government organizations, for overall market analysis ...
via Bing News